Capital Rx is a health technology company built around the mission of changing the way prescription drugs are priced and patients are serviced. Its Clearinghouse Model® is the first ethical framework for drug pricing. Capital Rx's enterprise pharmacy platform, JUDI®, connects every aspect of the pharmacy ecosystem in one platform. This company was founded in 2017 and is headquartered in New York, NY.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/28/2024 | Series E | $115MM | $xx.xx | $1.26B | Atlantic Health System, Banner Health, Hawai�i Pacific Health, Inova Health System, Lehigh Valley Health Network, Memorial Hermann Health System, Nebraska Medicine, Novant Health, Ochsner Health, WellSpan Health | |
Price per Share
$xx.xx
Shares Outstanding
16,282,494
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Atlantic Health System, Banner Health, Hawai�i Pacific Health, Inova Health System, Lehigh Valley Health Network, Memorial Hermann Health System, Nebraska Medicine, Novant Health, Ochsner Health, WellSpan Health
|
||||||
08/10/2023 | Series D | $72MM | $xx.xx | $1.02B | Memorial Hermann Health System | |
Price per Share
$xx.xx
Shares Outstanding
12,736,825
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Memorial Hermann Health System
|
||||||
06/13/2022 | Series C | $106MM | $xx.xx | $850.03MM | B Capital, General Catalyst, Transformation Capital, Edison Partners | |
Price per Share
$xx.xx
Shares Outstanding
20,909,771
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
B Capital, General Catalyst, Transformation Capital, Edison Partners
|
||||||
02/02/2021 | Series B | $50MM | $xx.xx | $251.49MM | Transformation Capital, Edison Partners | |
Price per Share
$xx.xx
Shares Outstanding
28,810,136
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Transformation Capital, Edison Partners
|
||||||
07/19/2019 | Series A | $16.38MM | $xx.xx | $79.62MM | Edison Partners, Emerald Development Managers | |
Price per Share
$xx.xx
Shares Outstanding
21,399,730
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Edison Partners, Emerald Development Managers
|
||||||
03/01/2018 | Series Seed | $3MM | $xx.xx | $15MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
15,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|